Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
02:12:13 EDT Sun 12 Apr 2026
Enter Symbol
or Name
USA
CA



Forgot password?
Trouble logging in?
Login ID:
Password:
Save

T:APLI - APPILI THERAPEUTICS INC. J - https://www.appilitherapeutics.com
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
APLI - T  817.00.015·0.021555.00.015-0.005-25.049.0150.015  0.015  0.0150.04  0.0111:15:45Mar 3015 min RT 2¢
TSX - T817.00.015·0.021555.00.015-0.005-25.05.220.015  0.015  0.0150.04  0.0110:46:4415 min
Omega - O 0.015-0.005-25.043.0110.015  0.015  0.01511:15:4515 min
CSE ATS - P 0.020.21    Feb 1815 min
MatchNOW - M 0.020.61    Sep 11/2015 min

Recent Trades - All 5 today
Time ETExPriceChangeVolumeBuyerSellerMarkers
12:04:25M0.02 6007 TD Sec7 TD SecE
11:15:45P0.015-0.0052477 TD Sec9 BMO NesbittE
11:15:45O0.015-0.00543,0001 Anonymous9 BMO NesbittK
10:46:44T0.015-0.0055,00080 National Bank80 National BankKL
09:30:00T0.02 15088 Credential7 TD Sec
        
        
        
        
        

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolPriceTypeHeadline
2026-03-30 07:19C:APLI0.02News ReleaseAppili Therapeutics to Exhibit at World Vaccine Congress Washington
2026-03-13 23:53C:APLI0.02MiscellaneousAppili Therapeutics under TSX delisting review
2026-02-18 17:34C:APLI0.02News ReleaseAppili Therapeutics closes $100,000 second tranche
2026-02-12 18:45C:APLI0.02SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2026-02-12 18:45C:APLI0.02SEDAR Interim MD & ASEDAR Interim MD & A
2026-02-12 18:15C:APLI0.02News ReleaseAppili Therapeutics Reports Financial and Operational Results for Third Quarter of Fiscal Year 2026
2025-12-18 18:34C:APLI0.025News ReleaseAppili closes $177,500 first tranche of placement
2025-11-13 18:42C:APLI0.025SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2025-11-13 18:42C:APLI0.025SEDAR Interim MD & ASEDAR Interim MD & A
2025-11-13 17:21C:APLI0.025News ReleaseAppili Therapeutics Reports Financial and Operational Results for Second Quarter of Fiscal Year 2026
2025-11-05 15:11C:APLI0.025News ReleaseAppili Therapeutics arranges $750,000 private placement
2025-10-22 07:20C:APLI0.03News ReleaseAppili Therapeutics to Attend BARDA Innovation Symposium 2025
2025-10-01 17:08C:APLI0.04News ReleaseAppili, Vitalex win up to $40M (U.S.) VXV-01 contract
2025-09-23 20:42C:APLI0.02News ReleaseAppili Therapeutics holders approve AGM resolutions
2025-09-09 07:20C:APLI0.015News ReleaseAppili Therapeutics to Present Progress on Tularemia Biodefense Vaccine at NATO CBRN Conference
2025-08-14 17:31C:APLI0.015SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2025-08-14 17:31C:APLI0.015SEDAR Interim MD & ASEDAR Interim MD & A
2025-08-14 17:05C:APLI0.015News ReleaseAppili Therapeutics Reports Financial and Operational Results for First Quarter of Fiscal Year 2026
2025-08-06 17:16C:APLI0.015News ReleaseAppili releases tularemia vaccine results
2025-06-25 20:49C:APLI0.015SEDAR Annual Information FormSEDAR Annual Information Form